Kidney International - Figure 2 for article: Production of cysteinyl-dopamine during intravenous dopamine therapy

FROM:

Production of cysteinyl-dopamine during intravenous dopamine therapy

Julia L Magnay, Jeff Tong, Rosa Drangova and Andrew D Baines

Figure 2.

Unfortunately we are unable to provide accessible alternative text for this. If you require assistance to access this image, please contact help@nature.com or the author

Unconjugated 5-S-cysteinyl dopamine (CYS-DA) expressed as a percentage of unconjugated dopamine (DA) in the plasma of patients undergoing dopamine treatment for acute illness. The percentage of CYS-DA/DA relative to the leukocyte count (WBC; A) is 7.6 + 0.36 $times$ WBC, and relative to the duration of dopamine treatment (days; B) is %CYS-DA/DA = 3.9 + 4.4 $times$ days, r = 0.38. The lines indicate the regression equation and 95% confidence limits.

Previous figureFigure and tables index

BACK TO ARTICLE

FIGURE 2

Production of cysteinyl-dopamine during intravenous dopamine therapy

Figure 2.